BOSTON, March 23, 2026 (GLOBE NEWSWIRE)-- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today provided a ...
Completed target enrollment in Phase 1 monotherapy dose expansion study of micvotabart pelidotin (MICVO) in 2L+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the first ...
NEW DELHI: The Pyxis Pioneer, a Singapore-flagged cargo vessel carrying liquefied petroleum gas (LPG) from Texas in the United States, docked at New Mangalore Port in Karnataka’s Mangaluru on ...
Investing.com - Stifel lowered its price target on Pyxis Oncology Inc. (NASDAQ:PYXS) to $8.00 from $9.00 while maintaining a Buy rating on the shares. The stock currently trades at $1.42, down 12% ...
Amid concerns of an LPG shortage due to the ongoing West Asia conflict, a fresh consignment of liquefied petroleum gas (LPG) has reached India from the US. The cargo vessel Pyxis Pioneer, carrying LPG ...
Meanwhile, Guggenheim has reiterated its Buy rating on Pyxis Oncology, maintaining a price target of $7.00, ahead of the anticipated phase 1 trial data for the MICVO candidate expected in mid-2026.
We recently compiled a list of the 12 Penny Stocks with Insider Buying in 2026. Pyxis Tankers Inc. (NASDAQ:PXS) is one of the best stocks with insider buying. TheFly reported on March 16 that Alliance ...
Pyxis Tankers Inc. operates as a maritime transportation company with a focus on the tanker and dry-bulk sectors in the United States and internationally. It operates through two segments: Tanker ...
Amid concerns of an LPG shortage due to the ongoing West Asia conflict, a fresh consignment of liquefied petroleum gas (LPG) has reached India from the US. The cargo vessel Pyxis Pioneer, carrying LPG ...
Weeping Peninsula (South Limgrave) - Dungeons, Points of Interest, and Secrets East Liurnia - Dungeons, Points of Interest, and Secrets North Liurnia - Dungeons, Points of Interest, and Secrets West ...
Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.